Other News

International

mRNA Cancer Vaccine: Moderna and Merck Report Phase 3 Success

In a landmark development for personalized medicine, pharmaceutical giants Moderna and Merck have announced positive results from their late-stage clinical trial evaluating an experimental mRNA-based therapy for advanced skin cancer. The milestone marks the first time a Phase 3 study has demonstrated statistically significant clinical benefits for a custom-tailored messenger […]